Posts tagged as

Benjamin Keselowsky

Publication by Dr. Benjamin Keselowsky featured in biomaterials book

UFDI researcher Dr. Benjamin Keselowsky’s paper ‘Biomaterials-Based Immunomodulation of Dendritic Cells’ was featured in Laura Santambrogio, M.D., Ph.D.’s latest book, Biomaterials in Regenerative Medicine and the Immune System. You can find Dr. Santambrogio’s book here.

Dr. Keselowsky named UF Research Foundation Professor

Benjamin Keselowsky, Ph.D., associate professor in the Department of Biodmedical Engineering, has been named a UF Research Foundation Professor for 2015-2018. Professor Keselowsky is using a $1.5M grant from the NIDDK to research novel methods for restoring cell function in Type 1 diabetes.

$1.5 million grant targets immune cell therapies in Type 1 diabetes

Benjamin Keselowsky, Ph.D. has received a new NIH R01 grant for “Biomaterial Delivery System for Type 1 Diabetes Vaccine”. Funded by the National Institute of Diabetes and Digestive and Kidney Diseases in collaboration with UF Diabetes Institute Director, Mark Atkinson, Ph.D., and Clive Wasserfall, this, $1.5M grant will fund the investigation of biodegradable microparticle/hydrogel formulations delivering immuno-modulatory factors to targeted immune cell types for the prevention and reversal of T1D.

Combining efforts to beat Type 1 diabetes

Learn about the latest drug-delivery system developed by University of Florida researches that holds the promise for ways to treat and ultimately prevent persons from developing Type 1 Diabetes. The joint effort is bringing research closer to a cure.